What the results of Wegovy’s longest clinical trial yet show about ...
May 13, 2024 · New analyses of the longest clinical trial yet of the weight-loss drug Wegovy are shedding light on how quickly it helps people lose weight, how long they sustain that weight loss and how safe...
FDA Approves First Treatment to Reduce Risk of Serious Heart …
Today, the U.S. Food and Drug Administration approved a new indication for use for Wegovy (semaglutide) injection to reduce the risk of cardiovascular death, heart attack and stroke in adults...
FDA approves Wegovy to reduce heart attack and stroke risk - NBC News
Mar 8, 2024 · The blockbuster weight loss drug Wegovy is now approved to reduce heart disease risk, drugmaker Novo Nordisk said Friday. The Food and Drug Administration has updated the drug's label, saying...
Wegovy approved to lessen heart attack, stroke risk in overweight ...
Mar 8, 2024 · The popular weight-loss drug can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, the FDA...
Weight-loss drug Wegovy produces ‘largest benefit ever seen’ for ...
Aug 25, 2023 · The study of 529 patients, funded by drugmaker Novo Nordisk, found that a 2.4-milligram weekly dose of semaglutide, sold as Wegovy for weight loss, led to an improvement of 17 points on a...
FDA Approves New Drug Treatment for Chronic Weight …
FDA approves Wegovy (semaglutide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition.
Wegovy shown to reduce risk of heart attack, stroke in major ...
Aug 8, 2023 · CNN — The weight loss drug Wegovy was shown to reduce the risk of heart attack, stroke or heart-related death by 20% in what’s being called a landmark clinical trial in people with cardiovascular...
Why weight-loss drug Wegovy shows promise for heart disease - NBC News
Nov 11, 2023 · The weight-loss drug Wegovy can reduce the risk of heart attacks and strokes by 20% in adults with heart disease and obesity, according to new research.
Wegovy shown to cut risk of stroke and heart attacks ... - NBC News
Aug 8, 2023 · The popular obesity drug Wegovy cuts the risk of cardiovascular events, such as heart attack and stroke, by 20%, drugmaker Novo Nordisk said Tuesday. The findings are the first to demonstrate...
Novo Nordisk Says Wegovy Improved Patients’ Liver Disease
Nov 1, 2024 · The trial showed that semaglutide, the main ingredient in Novo’s Wegovy, helped 37% of patients see an improvement in their liver fibrosis, while 62.9% achieved resolution of their liver disease ...